Arts Way director awarded 3,000 restricted shares

Buffamante Thomas E reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 04/22/2026 - 10:42 AM EDT

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Buffamante Thomas E reported acquisition or exercise transactions in this Form 4 filing.

ARTS WAY MANUFACTURING CO INC director Thomas E. Buffamante received a stock award of 3,000 common shares on April 21, 2026. The filing describes this as fully‑vested restricted stock granted under the director compensation plan, increasing his direct holdings to 63,000 common shares.

Insider Trade Summary

Grant/Award: 3,000 shares

Grant/Award 1 txn

Insider Buffamante Thomas E

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,000	$0.00	$0.00

Holdings After Transaction: Common Stock — 63,000 shares (Direct)

Footnotes (1)

F1. Represents fully-vested restricted stock granted pursuant to the director compensation plan.

Key Figures

Restricted stock grant: 3,000 shares Holdings after transaction: 63,000 shares Reported grant price: $0.0000 per share +1 more

4 metrics

Restricted stock grant 3,000 shares Fully-vested restricted common stock granted to director on April 21, 2026

Holdings after transaction 63,000 shares Total direct ARTW common stock owned by Thomas E. Buffamante after award

Reported grant price $0.0000 per share Accounting grant price per share for restricted stock award

Transaction code A (Grant, award, or other acquisition) Indicates equity award rather than open-market trade

Key Terms

restricted stock, director compensation plan, Common Stock, Grant, award, or other acquisition

4 terms

restricted stock financial

"Represents fully-vested restricted stock granted pursuant to the director compensation plan."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

director compensation plan financial

"Represents fully-vested restricted stock granted pursuant to the director compensation plan."

Common Stock financial

"security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did ARTW director Thomas E. Buffamante report in this Form 4?

Thomas E. Buffamante reported an acquisition of 3,000 shares of ARTW common stock. These were granted as fully-vested restricted stock under the director compensation plan, increasing his direct ownership to 63,000 shares after the transaction.

Was the ARTW insider transaction a market buy or part of compensation?

The transaction was part of director compensation, not a market purchase. The 3,000 common shares were granted as fully-vested restricted stock under the director compensation plan, with a reported price per share of $0.0000 in the filing.

How many ARTW shares does Thomas E. Buffamante hold after this grant?

After the award, Thomas E. Buffamante directly holds 63,000 shares of ARTW common stock. This total reflects the addition of 3,000 fully-vested restricted shares granted under the director compensation plan on April 21, 2026.

What type of security was involved in the ARTW Form 4 filing?

The filing involves ARTW common stock. Specifically, the director received 3,000 shares of fully-vested restricted stock, which are common shares granted under the company's director compensation plan rather than purchased in the open market.

What does the footnote in the ARTW Form 4 explain about the shares?

The footnote explains the 3,000 reported shares represent fully-vested restricted stock. They were granted pursuant to the company’s director compensation plan, clarifying that this is an equity award as part of compensation, not a discretionary open-market transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Buffamante Thomas E

(Last)

(First)

(Middle)

5556 HIGHWAY 9

(Street)

ARMSTRONG

IOWA

50514

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ARTS WAY MANUFACTURING CO INC [ ARTW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/21/2026		A		3,000⁽¹⁾	A	$0	63,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents fully-vested restricted stock granted pursuant to the director compensation plan.

	/s/ Michael W. Woods as Attorney-in-Fact for Thomas E. Buffamante	04/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR